Fadi N. Salloum

Dr. Salloum is the Natalie N. and John R. Congdon Sr. Endowed Chair at Virginia Commonwealth University (VCU) Health Pauley Heart Center. He received his PhD at VCU and completed his postdoctoral fellowship training in Molecular Cardiology in the Department of Internal Medicine at VCU. Dr. Salloum’s research focuses on understanding the molecular mechanisms and signaling pathways of cardiopulmonary and metabolic diseases in order to develop novel therapies to treat them. His laboratory is also focused on studying the role of novel or ‘repurposed’ drugs in cardioprotection against ischemia-related injury and adverse cardiac remodeling/failure through suppression of the NLRP3 inflammasome, as well as investigating methods to mitigate cardiotoxicity induced by various standard-of-care cancer chemotherapeutic drugs. Dr. Salloum served on the American Heart Association’s new Strategically Focused Research Network (SFRN) peer-review panel on heart failure and continuously serves as ad hoc reviewer on NIH study sections. He currently Co-Chairs the American Heart Association’s Cardiac Bio BSc 3 Peer-Review Committee. With over 100 peer-reviewed publications, Dr. Salloum has numerous active NIH-funded grants and has been previously funded by several AHA and Industry grants.